123 related articles for article (PubMed ID: 38705152)
1. Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
Attia A; Webb J; Connor K; Johnston CJC; Williams M; Gordon-Walker T; Rowe IA; Harrison EM; Stutchfield BM
Lancet Healthy Longev; 2024 May; 5(5):e346-e355. PubMed ID: 38705152
[TBL] [Abstract][Full Text] [Related]
2. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
4. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list.
Magder LS; Regev A; Mindikoglu AL
Transpl Int; 2012 Apr; 25(4):409-15. PubMed ID: 22299756
[TBL] [Abstract][Full Text] [Related]
5. Combining Donor and Recipient Age With Preoperative MELD and UKELD Scores for Predicting Survival After Liver Transplantation.
Kostakis ID; Iype S; Nasralla D; Davidson BR; Imber C; Sharma D; Pollok JM
Exp Clin Transplant; 2021 Jun; 19(6):570-579. PubMed ID: 34085606
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
Saldaña RS; Schrem H; Barthold M; Kaltenborn A
PLoS One; 2017; 12(1):e0170499. PubMed ID: 28129338
[TBL] [Abstract][Full Text] [Related]
7. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
8. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
[TBL] [Abstract][Full Text] [Related]
9. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation.
Ow MM; Erasmus P; Minto G; Struthers R; Joseph M; Smith A; Warshow UM; Cramp ME; Cross TJ
Liver Transpl; 2014 Sep; 20(9):1081-8. PubMed ID: 24805969
[TBL] [Abstract][Full Text] [Related]
10. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
11. Disparities in liver transplantation before and after introduction of the MELD score.
Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
[TBL] [Abstract][Full Text] [Related]
12. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
13. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
[TBL] [Abstract][Full Text] [Related]
14. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
Malik AK; Masson S; Allen E; Akyol M; Bathgate A; Davies M; Hidalgo E; Hudson M; Powell J; Taylor R; Zarankaite A; Manas DM;
Transplantation; 2019 Nov; 103(11):2304-2311. PubMed ID: 30830042
[TBL] [Abstract][Full Text] [Related]
15. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
[TBL] [Abstract][Full Text] [Related]
17. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
[TBL] [Abstract][Full Text] [Related]
19. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
20. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
